← Evidence map

ArticleThe Journal of rheumatology2025

Unveiling the Dual Benefits of Bosentan in Systemic Sclerosis: Risk and Relief.

Matthew R Lammi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39955092